Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
15.24
-0.26 (-1.68%)
At close: Nov 7, 2025, 4:00 PM EST
15.75
+0.51 (3.35%)
After-hours: Nov 7, 2025, 5:38 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
Biotechnology
14.02M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2023
Period Ending
Dec '23
United States
14.02M